C

Cybin Inc
AMEX:CYBN

Watchlist Manager
Cybin Inc
AMEX:CYBN
Watchlist
Price: 7.53 USD 2.17% Market Closed
Market Cap: 5.7B USD

Intrinsic Value

There is not enough data to reliably calculate the intrinsic value of CYBN.

The Intrinsic Value is calculated as the average of DCF and Relative values:

CYBN Intrinsic Value
Not Available
C
Base Case Scenario
Compare CYBN to

Fundamental Analysis

Company Overview
Loading...
Business Segments
Loading...
Economic Moat
Loading...
Earnings Call
Loading...
Management
Loading...
Contacts
Loading...
Bear Theses

Cybin is highly reliant on successful trial outcomes for CYB003 and other deuterated psilocybin analogs, meaning any clinical setbacks or prolonged timelines could significantly undermine investor confidence.

The regulatory landscape for psychedelics remains uncertain, and unanticipated delays in FDA or other global approvals could force Cybin to raise additional capital, diluting existing shareholders.

Intense competition from better-funded psychedelic firms and established biotech players may erode Cybin’s market share and hamper its ability to secure favorable partnerships.

Bull Theses

Cybin’s leading candidate, CYB003, is progressing in clinical trials and, if approved, could position the company at the forefront of next-generation psychedelic treatments for major depressive and addiction disorders.

The company’s emphasis on proprietary deuterated psilocybin derivatives and novel delivery mechanisms may strengthen Cybin’s intellectual property moat and lead to differentiated product offerings.

Recent strategic acquisitions and research collaborations expand Cybin’s pipeline, potentially accelerating its path to commercialization and securing a strong foothold in the emerging psychedelic medicine market.

Show More Less
How do you feel about CYBN?
Bearish
Neutral
Bullish
Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Balance Sheet Decomposition
Cybin Inc

Current Assets 143.7m
Cash & Short-Term Investments 118.7m
Receivables 4.1m
Other Current Assets 20.9m
Non-Current Assets 67.2m
PP&E 82k
Intangibles 67.1m
Current Liabilities 14.6m
Accounts Payable 14.6m
Non-Current Liabilities 44.5m
Long-Term Debt 44.5m
Efficiency

Free Cash Flow Analysis
Cybin Inc

Last Value
3-Years Average
FCF Margin
Conversion Rate

Earnings Waterfall
Cybin Inc

Revenue
0 CAD
Operating Expenses
-147.4m CAD
Operating Income
-147.4m CAD
Other Expenses
24.5m CAD
Net Income
-122.9m CAD
Fundamental Scores

CYBN Profitability Score
Profitability Due Diligence

Cybin Inc's profitability score is 28/100. The higher the profitability score, the more profitable the company is.

ROE is Increasing
ROIC is Increasing
Low 3Y Average Gross Margin
Low 3Y Average Net Margin
28/100
Profitability
Score

Cybin Inc's profitability score is 28/100. The higher the profitability score, the more profitable the company is.

CYBN Solvency Score
Solvency Due Diligence

Cybin Inc's solvency score is 82/100. The higher the solvency score, the more solvent the company is.

High Altman Z-Score
Short-Term Solvency
Long-Term Solvency
Low D/E
82/100
Solvency
Score

Cybin Inc's solvency score is 82/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

CYBN Price Targets Summary
Cybin Inc

There are no price targets for CYBN.
Lowest
Price Target
Not Available
Average
Price Target
Not Available
Highest
Price Target
Not Available
View Analyst Estimates
View Analyst Estimates

Dividends

Cybin Inc
does not pay dividends
Shareholder Yield

Current shareholder yield for CYBN is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
No dividends
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

Competitive Landscape

Company Market Cap Intrinsic Valuation Profitability Solvency Price Change
1Y 3Y 5Y